This project addresses immunological mechanisms that regulate chronic inflammation and remodeling in the respiratory tract. Mycoplasma pulmonis infection induces lifelong reorganization of the airway vasculature and mucosal epithelium and is a murine model of human chronic airway inflammation. Preliminary data suggest that M. pulmonis-related airway remodeling is regulated by T lymphocytes. The experiments in this proposal are designed to determine the mechanisms by which T cells regulate changes in the airways. The T cell response to M. pulmonis will be characterized and tested for its capacity to influence different aspects of airway remodeling. M. pulmonis-reactive T cells will be studied at the level of T cell receptor repertoire, cytokine phenotype and ability to induce immunopathology. Experiments will also address the physiological function of CD134, a member of the Tumor necrosis family of receptors that is prominently expressed on inflammatory T cells and which regulates the proliferation of T cells. These last experiments will focus on determining the mechanism by which CD134 influences T cell expansion and uncovering the circumstances in which CD134 function is most significant. These experiments will provide basic information about immunological mechanisms that influence the form and extent of airway remodeling in chronic airway inflammatory diseases. A better understanding of these mechanisms may suggest novel therapeutic targets and approaches for treating chronic airway disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL024136-24
Application #
6616338
Study Section
Project Start
2002-07-01
Project End
2003-06-30
Budget Start
Budget End
Support Year
24
Fiscal Year
2002
Total Cost
$142,703
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ma, Qiaoli; Dieterich, Lothar C; Ikenberg, Kristian et al. (2018) Unexpected contribution of lymphatic vessels to promotion of distant metastatic tumor spread. Sci Adv 4:eaat4758
Kim, Minah; Nitschké, Maximilian; Sennino, Barbara et al. (2018) Amplification of Oncolytic Vaccinia Virus Widespread Tumor Cell Killing by Sunitinib through Multiple Mechanisms. Cancer Res 78:922-937
Nitschké, Maximilian; Bell, Alexander; Karaman, Sinem et al. (2017) Retrograde Lymph Flow Leads to Chylothorax in Transgenic Mice with Lymphatic Malformations. Am J Pathol 187:1984-1997
Shepherd, Joanna; Fisher, Matthew; Welford, Abigail et al. (2017) The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-O-phosphate. Oncotarget 8:95648-95661
Baluk, Peter; Yao, Li-Chin; Flores, Julio C et al. (2017) Rapamycin reversal of VEGF-C-driven lymphatic anomalies in the respiratory tract. JCI Insight 2:
Greenland, John R; Wong, Charissa M; Ahuja, Rahul et al. (2016) Donor-Reactive Regulatory T Cell Frequency Increases During Acute Cellular Rejection of Lung Allografts. Transplantation 100:2090-8
Huang, Jennifer L; Woolf, Adrian S; Kolatsi-Joannou, Maria et al. (2016) Vascular Endothelial Growth Factor C for Polycystic Kidney Diseases. J Am Soc Nephrol 27:69-77
Caughey, George H (2016) Mast cell proteases as pharmacological targets. Eur J Pharmacol 778:44-55
Korhonen, Emilia A; Lampinen, Anita; Giri, Hemant et al. (2016) Tie1 controls angiopoietin function in vascular remodeling and inflammation. J Clin Invest 126:3495-510
Kim, Minah; Allen, Breanna; Korhonen, Emilia A et al. (2016) Opposing actions of angiopoietin-2 on Tie2 signaling and FOXO1 activation. J Clin Invest 126:3511-25

Showing the most recent 10 out of 593 publications